5-Fluorouracil simultaneously maintains methotrexate antineoplastic activity in human breast cancer and protects against methotrexate cytotoxicity in human bone marrow

Anticancer Research

Volumn 19, Issue 2 A, 1999, Pages 985-988

  Bowen, Donnell ^a   Johnson, Donna H ^a   Southerland, William M ^a   Hughes, Doris E ^a   Hawkins Jr , Morris ^a  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

5 fluorouracil; Breast cancer and bone marrow cells; High dose methotrexate

Indexed keywords

FLUOROURACIL; METHOTREXATE;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; BONE MARROW TOXICITY; BREAST CANCER; CANCER GROWTH; CELL GROWTH; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BONE MARROW; BREAST NEOPLASMS; DRUG SYNERGISM; FEMALE; FLUOROURACIL; HUMANS; MALE; METHOTREXATE; MICE;

EID: 0033034549     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Damon LE, Cadman E, Benz C: Enhancement of 5-fluorouracil antitumor effects by the prior administration of methotrexate. Pharmac Ther 43: 155-185, 1989.
2. White RM: 5-Fluorouracil modulates the toxicity of high dose methotrexate. J Clin Pharmacol 35: 1156-1165, 1995.
3. Bowen D, Bailey BD and Guernsey LA: Rate-limiting steps in the interactions of fluoropyrimidines and methotrexate. European J Cancer and Clin Oncol 20: 651-657, 1984.
4. Jolivet J, Schilsky RL, Bailey BD, Drake JC and Chabner BA: Synthesis, retention, and biological activity of methotrexate polyglutamates in cultured human breast cancer cells. J Clin Invest 70: 351-360, 1982.
5. Koizumi S, Curt GA, Fine RL, Griffin JD and Chabner BA: Formation of methotrexate polyglutmates in purified myeloid precursor cells from normal human bone marrow. J Clin Invest 75: 1008-1011, 1985.
6. Randall T and Weissman L: Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. Blood 89: 3596-3606, 1997.
7. 14C]formate incorporation into RNA and protein. European J Cancer 16: 893-899, 1980.
8. Robbins TJ, Bowen D, Bui QQ and Tran MT: Modulation of high-dose methotrexate toxicity by a non-toxic level of 5-fluorouracil.: Toxicology 41: 61-73, 1986.
9. Chabner BA, Allegra CJ, Curt GA, Clendeninn NJ, Baram J, Koizumi S, Drake JC and Jolivet J: Polyglutamation of methotrexate. Is methotrexate a prodrug? J Clin Invest 76: 907-912, 1985.
10. Fabre I, Fabre G and Goldman ID: Polyglutamation, an important element in methotrexate cytotoxicity and selectivity in tumor versus murine granulocyte progenitor cells in vitro. Cancer Res 44: 3190-3195, 1984.
11. Matthews RG and Baugh CM: Interactions of pig liver methylenetetrahydrofolate reductase with methylenetetrahydropteroylpolyglutamate substrates and with dihydropteroyl polyglutamate inhibitors. Biochemistry 19: 2040-2045, 1980.